Expert consensus on prescribing restrictions that prevent primary care providers (PCPs) in Europe from initiating single-inhaler triple therapy (SITT)
Chronic Obstructive Pulmonary Disease (COPD) is a progressive condition that places a significant burden on patients and healthcare systems. Guidelines recommend triple therapy for patients with moderate-to-severe COPD whose disease remains inadequately controlled despite receiving dual therapy. This can be delivered either via multiple inhalers (MITT) or a single inhaler (SITT). SITT has been shown Read More >
Analysing the COPD care pathway in Japan, Canada, England and Germany: a global view
Aquarius Population Health are delighted to be collaborating with AstraZeneca on a poster session at this year’s European Respiratory Society International Congress. Our research, based on clinician interviews and local data reviews, advances our understanding of COPD care pathways in Japan, Canada, England and Germany, and identifies cross cutting barriers to optimal COPD care, which Read More >